Literature DB >> 18390487

Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice.

I Murano1, G Barbatelli, V Parisani, C Latini, G Muzzonigro, M Castellucci, S Cinti.   

Abstract

Accumulation of visceral fat is a key phenomenon in the onset of obesity-associated metabolic disorders. Macrophage infiltration induces chronic mild inflammation widely considered as a causative factor for insulin resistance and eventually diabetes. We previously showed that >90% of macrophages infiltrating the adipose tissue of obese animals and humans are arranged around dead adipocytes, forming characteristic crown-like structures (CLS). In this study we quantified CLS in visceral and subcutaneous depots from two strains of genetically obese mice, db/db and ob/ob. In both strains, CLS were prevalent in visceral compared with subcutaneous fat. Adipocyte size and CLS density exhibited a positive correlation both in visceral and in subcutaneous depots; however, the finding that adipocyte size was smallest and CLS density highest in visceral fat suggests a different susceptibility of visceral and subcutaneous adipocytes to death. Visceral fat CLS density was 3.4-fold greater in db/db than in ob/ob animals, which at the age at which our experimental strain was used are more prone to glucose metabolic disorders.

Entities:  

Mesh:

Year:  2008        PMID: 18390487     DOI: 10.1194/jlr.M800019-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  244 in total

Review 1.  Immunomodulation at epithelial sites by obesity and metabolic disease.

Authors:  Kitty P Cheung; Kristen R Taylor; Julie M Jameson
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

2.  Tissue-specific expression of Sprouty1 in mice protects against high-fat diet-induced fat accumulation, bone loss and metabolic dysfunction.

Authors:  Sumithra Urs; Terry Henderson; Phuong Le; Clifford J Rosen; Lucy Liaw
Journal:  Br J Nutr       Date:  2011-12-06       Impact factor: 3.718

Review 3.  Adipokines as novel biomarkers and regulators of the metabolic syndrome.

Authors:  Yingfeng Deng; Philipp E Scherer
Journal:  Ann N Y Acad Sci       Date:  2010-11       Impact factor: 5.691

Review 4.  Mechanisms of inflammatory responses in obese adipose tissue.

Authors:  Shengyi Sun; Yewei Ji; Sander Kersten; Ling Qi
Journal:  Annu Rev Nutr       Date:  2012-03-09       Impact factor: 11.848

5.  Time course of histomorphological changes in adipose tissue upon acute lipoatrophy.

Authors:  I Murano; J M Rutkowski; Q A Wang; Y-R Cho; P E Scherer; S Cinti
Journal:  Nutr Metab Cardiovasc Dis       Date:  2012-06-08       Impact factor: 4.222

6.  Adipose tissue inflammation and reduced insulin sensitivity in ovariectomized mice occurs in the absence of increased adiposity.

Authors:  Victoria J Vieira Potter; Katherine J Strissel; Chen Xie; Eugene Chang; Grace Bennett; Jason Defuria; Martin S Obin; Andrew S Greenberg
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

7.  Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity.

Authors:  Nicole H Rogers; James W Perfield; Katherine J Strissel; Martin S Obin; Andrew S Greenberg
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

8.  C1q/TNF-related protein 6 (CTRP6) links obesity to adipose tissue inflammation and insulin resistance.

Authors:  Xia Lei; Marcus M Seldin; Hannah C Little; Nicholas Choy; Thomas Klonisch; G William Wong
Journal:  J Biol Chem       Date:  2017-07-18       Impact factor: 5.157

9.  Control of adipose tissue expandability in response to high fat diet by the insulin-like growth factor-binding protein-4.

Authors:  Olga Gealekman; Kunal Gurav; My Chouinard; Juerg Straubhaar; Michael Thompson; Samir Malkani; Celia Hartigan; Silvia Corvera
Journal:  J Biol Chem       Date:  2014-04-28       Impact factor: 5.157

Review 10.  Adipose tissue inflammation in glucose metabolism.

Authors:  H L Kammoun; M J Kraakman; M A Febbraio
Journal:  Rev Endocr Metab Disord       Date:  2014-03       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.